1. Home
  2. JJSF vs AGIO Comparison

JJSF vs AGIO Comparison

Compare JJSF & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo J & J Snack Foods Corp.

JJSF

J & J Snack Foods Corp.

HOLD

Current Price

$82.73

Market Cap

1.7B

ML Signal

HOLD

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$27.81

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JJSF
AGIO
Founded
1971
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.7B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
JJSF
AGIO
Price
$82.73
$27.81
Analyst Decision
Strong Buy
Buy
Analyst Count
3
8
Target Price
$138.33
$36.25
AVG Volume (30 Days)
222.7K
939.7K
Earning Date
02-03-2026
02-12-2026
Dividend Yield
3.36%
N/A
EPS Growth
N/A
N/A
EPS
3.36
N/A
Revenue
$1,583,233,000.00
$44,791,000.00
Revenue This Year
$4.22
$27.83
Revenue Next Year
$2.24
$133.46
P/E Ratio
$28.33
N/A
Revenue Growth
0.54
36.26
52 Week Low
$80.67
$22.24
52 Week High
$144.37
$46.00

Technical Indicators

Market Signals
Indicator
JJSF
AGIO
Relative Strength Index (RSI) 27.27 48.17
Support Level $93.11 $26.53
Resistance Level $97.28 $29.93
Average True Range (ATR) 3.38 1.21
MACD -0.98 0.07
Stochastic Oscillator 9.77 42.26

Price Performance

Historical Comparison
JJSF
AGIO

About JJSF J & J Snack Foods Corp.

J&J Snack Foods Corp. manufactures snack foods and distributes frozen beverages, which it markets nationally to the foodservice and retail supermarket industries. The company's portfolio of frozen beverages, frozen novelties, and baked goods includes soft pretzels, frozen juice treats and desserts, stuffed sandwiches, churros, funnel cakes, cookies, and other snack foods and drinks. It operates through three segments: Food Service, which sells snacks, desserts, and baked goods at the point of sale; Retail Supermarkets, which sells frozen and prepackaged products to supermarkets; and Frozen Beverages, which sells frozen beverages under the ICEE, Slush Puppie, and Parrot Ice brands in the United States, Mexico, and Canada. The majority of revenue comes from the Food Service segment.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

Share on Social Networks: